ICMR to Commercialise Indigenous Malaria Vaccine
The Indian Council of Medical Research (ICMR) has taken a major step in public health innovation by initiating the process to commercialise a recombinant multi-stage malaria vaccine, AdFalciVax. ICMR has released an Expression of Interest (EoI) inviting pharmaceutical companies and manufacturers to collaborate in transferring the technology and mass-producing the vaccine, aiming to tackle Plasmodium falciparum, the most deadly malaria parasite in humans.
India reports a large burden of malaria cases, especially from Plasmodium falciparum in tribal and underdeveloped regions. An indigenously developed vaccine can improve accessibility, affordability, and reduce dependence on global vaccine suppliers. It also aligns with India’s public health goal to eliminate malaria by 2030.
Asia is one of the fastest-growing regions in the world and is home to many…
India has formally begun preparing its military leadership for the wars of the future. On…
Union Bank of India has announced a key leadership change with the promotion of Shri…
India’s biodiversity has gained fresh attention after scientists discovered a new orchid species in Kerala’s…
Punjab’s aviation map witnessed a symbolic and developmental shift on 2 February 2026. Prime Minister…
Indian badminton has a new rising star. Devika Sihag, a 20-year-old shuttler from Haryana, has…